InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by MIGAUSKY GEORGE V, Directeur. Officer active across 2 companies, notably Immunovant, Inc.. Cumulatively, 5 filings have been published. Total volume traded: €92k. The latest transaction was filed on 3 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
03,010 shares0
Common Stock
SEC:0001562180-22-004879:0·
021,726 shares0
Common Stock
SEC:0001764013-22-000019·
021,726 shares0
Common Stock
SEC:0001764013-22-000019:0·
€45,8617,000 shares@ €6.55160.0008% mcap100.0% of flow
Common Stock
SEC:0001764013-21-000090·
Ideal exit: 17 May 2022 (T+270)
€45,8617,000 shares@ €6.55160.0008% mcap50.0% of flow
Common Stock
SEC:0001764013-21-000090:0·
Ideal exit: 17 May 2022 (T+270)
5 of 5 declarations
About MIGAUSKY GEORGE V
George V. Migausky is a Director at Immunovant, Inc. and REGENXBIO Inc. In this role, he provides his expertise to the board of directors to guide the strategy of the companies. George is involved in evaluating performance and initiatives that support growth objectives. His experience in the biopharmaceutical sector is valuable for both companies.
